Investigators studied the prevalence and outcomes of venous thromboembolic events (VTEs) among hospitalized patients with and without CKD.

CHICAGO -- For extended anticoagulation after venous thromboembolism (VTE) in patients with active cancer, a lower dose of apixaban (Eliquis) was just as effective as a higher dose -- and safer, the ...

A recent study found that following a plant-based diet could significantly reduce the risk of VTE, or venous thromboembolism ...

Researchers sought to determine whether contemporary hormonal contraception methods are associated with risk of developing VTE.

But it can happen anywhere. If DVT goes untreated, it can become life-threatening — a condition called venous thromboembolism (VTE). Your blood clots can break up inside your vein. The smaller ...

Purpose Published evidence on the incidence and predictors of venous thromboembolism (VTE) in patients with cirrhosis of the liver is reviewed. Summary The frequently observed phenomenon of ...

Patients with active cancer who developed a blood clot, or venous thromboembolism (VTE), and were treated with blood-thinning medication for at least six months, followed by an additional 12 months of ...

SonoVascular, Inc., a clinical stage medical device company focused on bringing to market its SonoThrombectomy™ System, a safer and more effective treatment of venous thromboembolism (VTE), was ...

Patients with cancer and VTE are at risk for VTE recurrence, and there are limited data on appropriate and effective anticoagulation regimens beyond 6 months. New research findings are summarized ...

Advances has found that consuming a healthy plant-based diet could reduce the risk of dangerous blood clots in the legs ...

The Phase III API-CAT trial found that extended anticoagulant therapy with reduced-dose Eliquis (apixaban) was noninferior to the full-dose regimen in preventing recurrent venous thromboembolism in ...